Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients
Clinical trial NCT04226105 · UNKNOWN
Trial details
- NCT number
- NCT04226105
- Sponsor
- Geropharm
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-20
- Primary completion
- 2020-09-30
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.